LLPS-Man-3991
APOE
Integrated Annotations
▼ OVERVIEW
Status: | Unreviewed |
Protein Name: | Apolipoprotein E |
Gene Name: | APOE |
Ensembl Gene: | ENSMNEG00000032951.1 |
Ensembl Protein: | ENSMNEP00000017988.1 |
Organism: | Macaca nemestrina |
Taxa ID: | 9545 |
LLPS Type: | LLPS regulator |
▼ Classification
Condensates:
Condensate | Evidence | Orthologs |
---|---|---|
Stress granule, Postsynaptic density | Predicted from orthologs | (View) |
▼ FUNCTION
APOE is an apolipoprotein, a protein associating with lipid particles, that mainly functions in lipoprotein-mediated lipid transport between organs via the plasma and interstitial fluids. APOE is a core component of plasma lipoproteins and is involved in their production, conversion and clearance. Apoliproteins are amphipathic molecules that interact both with lipids of the lipoprotein particle core and the aqueous environment of the plasma. As such, APOE associates with chylomicrons, chylomicron remnants, very low density lipoproteins (VLDL) and intermediate density lipoproteins (IDL) but shows a preferential binding to high-density lipoproteins (HDL). It also binds a wide range of cellular receptors including the LDL receptor/LDLR, the LDL receptor-related proteins LRP1, LRP2 and LRP8 and the very low-density lipoprotein receptor/VLDLR that mediate the cellular uptake of the APOE-containing lipoprotein particles. Finally, APOE has also a heparin-binding activity and binds heparan-sulfate proteoglycans on the surface of cells, a property that supports the capture and the receptor-mediated uptake of APOE-containing lipoproteins by cells. A main function of APOE is to mediate lipoprotein clearance through the uptake of chylomicrons, VLDLs, and HDLs by hepatocytes. APOE is also involved in the biosynthesis by the liver of VLDLs as well as their uptake by peripheral tissues ensuring the delivery of triglycerides and energy storage in muscle, heart and adipose tissues. By participating to the lipoprotein-mediated distribution of lipids among tissues, APOE plays a critical role in plasma and tissues lipid homeostasis. APOE is also involved in two steps of reverse cholesterol transport, the HDLs-mediated transport of cholesterol from peripheral tissues to the liver, and thereby plays an important role in cholesterol homeostasis. First, it is functionally associated with ABCA1 in the biogenesis of HDLs in tissues. Second, it is enriched in circulating HDLs and mediates their uptake by hepatocytes. APOE also plays an important role in lipid transport in the central nervous system, regulating neuron survival and sprouting. |
▼ CROSS REFERENCE
Database | Nucleotide ID | Protein ID |
---|---|---|
Ensembl | ENSMNET00000042220.1 | ENSMNEP00000017988.1 |
UniProt | P0DO94, APOE_MACNE | |
GeneBank | JZLF01080368 |
▼ SEQUENCE
Protein Sequence (FASTA) |
---|
1 MKVLWAALLV TFLAGCQAKV EQPVEPETEP ELRQQAEGQS GQPWELALGR FWDYLRWVQT 60 61 LSEQVQEELL SPQVTQELTT LMDETMKELK AYKSELEEQL SPVAEETRAR LSKELQAAQA 120 121 RLGADMEDVR SRLVQYRSEV QAMLGQSTEE LRARLASHLR KLRKRLLRDA DDLQKRLAVY 180 181 QAGAREGAER GVSAIRERLG PLVEQGRVRA ATVGSLASQP LQERAQALGE RLRARMEEMG 240 241 SRTRDRLDEV KEQVAEVRAK LEEQAQQISL QAEAFQARLK SWFEPLVEDM QRQWAGLVEK 300 301 VQAAVGASTA PVPSDNH 317 |
Nucleotide CDS Sequence (FASTA) |
1 ATGAAGGTTC TGTGGGCTGC GTTGCTGGTC ACATTCCTGG CAGGATGCCA GGCCAAGGTG 60 61 GAGCAACCGG TGGAGCCAGA GACGGAACCC GAGCTTCGCC AGCAGGCTGA GGGGCAGAGC 120 121 GGCCAGCCCT GGGAGCTGGC ACTGGGTCGC TTTTGGGATT ACCTGCGCTG GGTGCAGACA 180 181 CTGTCTGAGC AGGTGCAGGA GGAGCTGCTC AGCCCCCAGG TCACCCAGGA ACTGACGACG 240 241 CTGATGGATG AGACCATGAA GGAGTTGAAG GCCTACAAAT CGGAACTGGA GGAACAGCTG 300 301 AGCCCGGTGG CGGAGGAGAC GCGGGCACGG CTGTCCAAGG AGCTGCAGGC GGCGCAGGCC 360 361 CGGCTGGGTG CCGACATGGA GGACGTGCGC AGCCGCCTGG TGCAGTACCG CAGCGAGGTG 420 421 CAGGCCATGC TGGGCCAGAG TACCGAGGAG CTGCGGGCGC GCCTCGCCTC CCACCTGCGC 480 481 AAGCTGCGCA AGCGGCTCCT CCGCGATGCT GATGACCTGC AGAAGCGCCT GGCAGTGTAT 540 541 CAGGCCGGGG CCCGCGAGGG CGCCGAGCGC GGGGTCAGCG CCATCCGCGA GCGCCTGGGA 600 601 CCCCTGGTGG AGCAGGGCCG CGTGCGGGCC GCCACTGTGG GCTCCCTGGC CAGCCAGCCG 660 661 CTTCAGGAGC GGGCCCAGGC CTTGGGTGAG CGGCTTCGCG CACGGATGGA GGAGATGGGC 720 721 AGCCGGACCC GCGACCGCCT GGACGAGGTG AAGGAGCAGG TGGCGGAGGT GCGCGCCAAG 780 781 CTGGAGGAAC AGGCCCAGCA GATAAGCCTG CAGGCCGAGG CCTTCCAGGC CCGCCTCAAG 840 841 AGCTGGTTCG AGCCCCTGGT GGAAGACATG CAGCGCCAGT GGGCTGGGCT GGTGGAGAAG 900 901 GTGCAGGCTG CCGTGGGCGC CAGCACTGCC CCTGTGCCCA GCGACAATCA CTGA 954 |
▼ KEYWORD
ID | Family |
Chylomicron | |
Complete proteome | |
Extracellular matrix | |
Glycoprotein | |
HDL | |
Heparin-binding | |
Lipid transport | |
Lipid-binding | |
Oxidation | |
Phosphoprotein | |
Reference proteome | |
Repeat | |
Secreted | |
Signal | |
Transport | |
VLDL
|
▼ GENE ONTOLOGY
ID | Classification | Description |
Cellular Component | Chylomicron | |
Cellular Component | Endoplasmic reticulum | |
Cellular Component | Extracellular matrix | |
Cellular Component | Extracellular space | |
Cellular Component | Glutamatergic synapse | |
Cellular Component | Golgi apparatus | |
Cellular Component | High-density lipoprotein particle | |
Cellular Component | Intermediate-density lipoprotein particle | |
Cellular Component | Low-density lipoprotein particle | |
Cellular Component | Plasma membrane | |
Cellular Component | Synaptic cleft | |
Cellular Component | Very-low-density lipoprotein particle | |
Molecular Function | Amyloid-beta binding | |
Molecular Function | Antioxidant activity | |
Molecular Function | Cholesterol transporter activity | |
Molecular Function | Heparan sulfate proteoglycan binding | |
Molecular Function | Heparin binding | |
Molecular Function | Identical protein binding | |
Molecular Function | Lipoprotein particle binding | |
Molecular Function | Low-density lipoprotein particle receptor binding | |
Molecular Function | Metal chelating activity | |
Molecular Function | Phosphatidylcholine-sterol O-acyltransferase activator activity | |
Molecular Function | Phospholipid binding | |
Molecular Function | Protein homodimerization activity | |
Molecular Function | Tau protein binding | |
Molecular Function | Very-low-density lipoprotein particle receptor binding | |
Biological Process | AMPA glutamate receptor clustering | |
Biological Process | Amyloid precursor protein metabolic process | |
Biological Process | Artery morphogenesis | |
Biological Process | Cellular calcium ion homeostasis | |
Biological Process | CGMP-mediated signaling | |
Biological Process | Cholesterol catabolic process | |
Biological Process | Cholesterol efflux | |
Biological Process | Cholesterol homeostasis | |
Biological Process | Chylomicron remnant clearance | |
Biological Process | Fatty acid homeostasis | |
Biological Process | G protein-coupled receptor signaling pathway | |
Biological Process | High-density lipoprotein particle assembly | |
Biological Process | High-density lipoprotein particle clearance | |
Biological Process | High-density lipoprotein particle remodeling | |
Biological Process | Intermediate-density lipoprotein particle clearance | |
Biological Process | Lipid transport involved in lipid storage | |
Biological Process | Lipoprotein biosynthetic process | |
Biological Process | Lipoprotein catabolic process | |
Biological Process | Locomotory exploration behavior | |
Biological Process | Long-chain fatty acid transport | |
Biological Process | Long-term memory | |
Biological Process | Low-density lipoprotein particle remodeling | |
Biological Process | Maintenance of location in cell | |
Biological Process | Negative regulation of amyloid-beta formation | |
Biological Process | Negative regulation of blood vessel endothelial cell migration | |
Biological Process | Negative regulation of canonical Wnt signaling pathway | |
Biological Process | Negative regulation of cholesterol biosynthetic process | |
Biological Process | Negative regulation of endothelial cell proliferation | |
Biological Process | Negative regulation of gene expression | |
Biological Process | Negative regulation of inflammatory response | |
Biological Process | Negative regulation of long-term synaptic potentiation | |
Biological Process | Negative regulation of MAP kinase activity | |
Biological Process | Negative regulation of neuron death | |
Biological Process | Negative regulation of neuron projection development | |
Biological Process | Negative regulation of platelet activation | |
Biological Process | Negative regulation of presynaptic membrane organization | |
Biological Process | Negative regulation of triglyceride metabolic process | |
Biological Process | Neuron projection development | |
Biological Process | Nitric oxide mediated signal transduction | |
Biological Process | NMDA glutamate receptor clustering | |
Biological Process | Phospholipid efflux | |
Biological Process | Positive regulation by host of viral process | |
Biological Process | Positive regulation of cholesterol efflux | |
Biological Process | Positive regulation of cholesterol esterification | |
Biological Process | Positive regulation of dendritic spine development | |
Biological Process | Positive regulation of dendritic spine maintenance | |
Biological Process | Positive regulation of endocytosis | |
Biological Process | Positive regulation of ERK1 and ERK2 cascade | |
Biological Process | Positive regulation of heparan sulfate binding | |
Biological Process | Positive regulation of heparan sulfate proteoglycan binding | |
Biological Process | Positive regulation of lipid biosynthetic process | |
Biological Process | Positive regulation of lipid transport across blood-brain barrier | |
Biological Process | Positive regulation of low-density lipoprotein particle receptor catabolic process | |
Biological Process | Positive regulation of membrane protein ectodomain proteolysis | |
Biological Process | Positive regulation of nitric-oxide synthase activity | |
Biological Process | Positive regulation of phospholipid efflux | |
Biological Process | Positive regulation of postsynaptic membrane organization | |
Biological Process | Positive regulation of transcription, DNA-templated | |
Biological Process | Protein import | |
Biological Process | Receptor-mediated endocytosis | |
Biological Process | Regulation of amyloid fibril formation | |
Biological Process | Regulation of amyloid-beta clearance | |
Biological Process | Regulation of apoptotic process | |
Biological Process | Regulation of behavioral fear response | |
Biological Process | Regulation of Cdc42 protein signal transduction | |
Biological Process | Regulation of cellular response to very-low-density lipoprotein particle stimulus | |
Biological Process | Regulation of innate immune response | |
Biological Process | Regulation of proteasomal protein catabolic process | |
Biological Process | Regulation of protein homooligomerization | |
Biological Process | Response to caloric restriction | |
Biological Process | Response to dietary excess | |
Biological Process | Response to oxidative stress | |
Biological Process | Reverse cholesterol transport | |
Biological Process | Triglyceride homeostasis | |
Biological Process | Triglyceride metabolic process | |
Biological Process | Triglyceride-rich lipoprotein particle clearance | |
Biological Process | Vasodilation | |
Biological Process | Very-low-density lipoprotein particle clearance | |
Biological Process | Very-low-density lipoprotein particle remodeling | |
Biological Process | Virion assembly |
▼ ORTHOLOGY
DrLLPS ID | Organism | Identity | E-value | Score |
---|---|---|---|---|
LLPS-Mam-1368 | Macaca mulatta | 100.0 | 0.0 | 527 |
LLPS-Maf-1827 | Macaca fascicularis | 100.0 | 0.0 | 527 |
LLPS-Paa-3152 | Papio anubis | 99.68 | 0.0 | 523 |
LLPS-Chs-0229 | Chlorocebus sabaeus | 99.05 | 0.0 | 518 |
LLPS-Cea-2931 | Cercocebus atys | 98.42 | 0.0 | 516 |
LLPS-Rhb-0795 | Rhinopithecus bieti | 97.48 | 0.0 | 511 |
LLPS-Pap-2285 | Pan paniscus | 94.32 | 3e-174 | 493 |
LLPS-Pat-1114 | Pan troglodytes | 94.32 | 3e-174 | 493 |
LLPS-Poa-4468 | Pongo abelii | 94.32 | 1e-173 | 491 |
LLPS-Hos-0967 | Homo sapiens | 93.69 | 2e-172 | 488 |
LLPS-Caj-2708 | Callithrix jacchus | 90.62 | 2e-168 | 478 |
LLPS-Nol-0037 | Nomascus leucogenys | 87.07 | 9e-149 | 428 |
LLPS-Otg-4113 | Otolemur garnettii | 81.45 | 7e-145 | 418 |
LLPS-Bot-1420 | Bos taurus | 75.0 | 4e-122 | 361 |
LLPS-Ran-4859 | Rattus norvegicus | 74.04 | 4e-123 | 364 |
LLPS-Fec-3304 | Felis catus | 73.85 | 3e-106 | 319 |
LLPS-Mup-0859 | Mustela putorius furo | 73.67 | 5e-129 | 378 |
LLPS-Tut-1541 | Tursiops truncatus | 73.5 | 5e-131 | 383 |
LLPS-Sus-2619 | Sus scrofa | 73.18 | 1e-124 | 367 |
LLPS-Mea-1347 | Mesocricetus auratus | 72.93 | 2e-132 | 387 |
LLPS-Aon-1141 | Aotus nancymaae | 72.31 | 1e-130 | 380 |
LLPS-Cap-0067 | Cavia porcellus | 72.29 | 8e-125 | 366 |
LLPS-Eqc-1143 | Equus caballus | 72.24 | 4e-127 | 373 |
LLPS-Ova-4225 | Ovis aries | 70.98 | 2e-124 | 366 |
LLPS-Mum-3610 | Mus musculus | 70.13 | 8e-131 | 382 |
LLPS-Loa-3477 | Loxodonta africana | 70.03 | 1e-125 | 369 |
LLPS-Caf-1692 | Canis familiaris | 69.91 | 3e-122 | 361 |
LLPS-Fud-4360 | Fukomys damarensis | 68.0 | 3e-58 | 193 |
LLPS-Aim-0812 | Ailuropoda melanoleuca | 66.78 | 3e-105 | 317 |
LLPS-Myl-2614 | Myotis lucifugus | 64.89 | 6e-111 | 332 |
LLPS-Dio-3677 | Dipodomys ordii | 64.47 | 6e-107 | 320 |
LLPS-Mod-2122 | Monodelphis domestica | 48.74 | 3e-59 | 198 |
LLPS-Sah-3036 | Sarcophilus harrisii | 45.76 | 2e-40 | 147 |
LLPS-Ora-3487 | Ornithorhynchus anatinus | 41.44 | 8e-51 | 176 |
LLPS-Leo-2501 | Lepisosteus oculatus | 32.71 | 2e-13 | 71.2 |
LLPS-Dar-3412 | Danio rerio | 29.14 | 3e-21 | 95.5 |
LLPS-Orn-2719 | Oreochromis niloticus | 29.11 | 6e-24 | 103 |
LLPS-Gaa-0219 | Gasterosteus aculeatus | 28.27 | 2e-20 | 93.2 |
LLPS-Tar-2210 | Takifugu rubripes | 27.71 | 2e-18 | 87.0 |
LLPS-Lac-3372 | Latimeria chalumnae | 27.51 | 6e-27 | 112 |
LLPS-Scm-0225 | Scophthalmus maximus | 27.04 | 2e-21 | 95.9 |
LLPS-Scf-1952 | Scleropages formosus | 26.64 | 5e-24 | 103 |
LLPS-Asm-2917 | Astyanax mexicanus | 26.49 | 1e-21 | 96.7 |
LLPS-Icp-2604 | Ictalurus punctatus | 26.03 | 1e-20 | 94.0 |
LLPS-Xet-2377 | Xenopus tropicalis | 24.71 | 1e-18 | 87.8 |